Screening for the detection of angiotensin-converting enzyme inhibitors, their metabolites, and at II receptor antagonists

Therapeutic Drug Monitoring

Volumn 20, Issue 6, 1998, Pages 706-713

  Maurer, Hans H ^a   Kraemer, Thomas ^a   Arlt, Joachim W ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Acidic drugs; Angiotensin II receptor antagonists; Angiotensin converting enzyme inhibitors; Extractive methylation; Gas chromatography mass spectrometry; Metabolism; Systematic toxicologic analysis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BENAZEPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG METABOLITE; ENALAPRIL; LOSARTAN; MOEXIPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL; TRANDOLAPRIL; VALSARTAN;

ARTICLE; DRUG DETERMINATION; DRUG SCREENING; DRUG URINE LEVEL; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; METHYLATION; NONHUMAN; PRIORITY JOURNAL; SOLID PHASE EXTRACTION; TOXICOLOGICAL PARAMETERS;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METHYLATION; RECEPTORS, ANGIOTENSIN;

EID: 0031785953     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199812000-00022     Document Type: Article

References (36)

1. Arlt JW. Doctoral thesis, University of Saarland, Homburg/Saarbrücken, 1998.
2. Hammes W, Hammes B, Buchsler U, et al. Simultaneous determination of moexipril and moexiprilat, its active metabolite, in human plasma by gas chromatography-negative-ion chemical ionization mass spectrometry. J Chromatogr B 1995;670:81-9.
3. Shioya H, Shimojo M, Kawahara Y. Determination of enalapril and its active metabolite enalaprilat in plasma and urine by gas chromatography/mass spectrometry. Biomed Chromatogr 1992;6: 59-62.
4. Goto N, Sato T, Shigetoshi M, et al. Determination of dioxopiperazine metabolites of quinapril in biological fluids by gas chromatography-mass spectrometry. J Chromatogr 1992;578:203-6.
5. Goto N, Kamata T, Ikegami K. Trace analysis of quinapril and its active metabolite, quinaprilat, in human plasma and urine by gas chromatography-negative-ion chemical ionization mass spectrometry. J Chromatogr 1992;578:195-201.
6. Tsaconas C, Devissaguet M, Padieu P. Gas chromatography-mass spectrometry of perindopril and its active free metabolite, an angiotensin convertase inhibitor: choice of derivatives and ionization modes. J Chromatogr 1989;488:249-65.
7. Sioufi A, Pommier F, Kaiser G, et al. Determination of benazepril, a new angiotensin-converting enzyme inhibitor, and its active metabolite, benazeprilat, in plasma and urine by capillary gas chromatography-mass-selective detection. J Chromatogr 1988;434: 239-46.
8. Kaiser G, Ackermann R, Dieterle W, et al. Determination of a new angiotensin converting enzyme inhibitor and its active metabolite in plasma and urine by gas chromatography-mass spectrometry. J Chromatogr 1987;419:123-33.
9. Ferry JJ, Horvath AM, Easton Taylor M, et al. Determination of quinapril and its active metabolite in human plasma and urine by gas chromatography with electron-capture detection. J Chromatogr 1987;421:187-91.
10. Furtek CI, Lo MW. Simultaneous determination of a novel angiotensin II receptor blocking agent, losartan, and its metabolite in human plasma and urine by high-performance liquid chromatography. J Chromatogr 1992;573:295-301.
11. Maurer HH. On the metabolism and the toxicological analysis of methylenedioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry. Ther Drug Monit 1996;18:465-70.
12. Maurer HH. Systematic toxicological analysis of drugs and their metabolites by gas chromatography-mass spectrometry. J Chromatogr 1992;580:3-41.
13. Maurer HH, Arlt JW, Kraemer T, et al. Analytical development for low molecular weight xenobiotic compounds. Arch Toxicol Suppl 1997;19:189-97.
14. Maurer HH, Arlt JW. Detection of 4-hydroxycoumarin anticoagulants and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry (GC-MS) after extractive methylation. J Chromatogr B 1998;714:181-95.
15. Maurer HH, Arlt JW. Screening procedure for detection of dihydropyridine calcium channel blocker metabolites in urine as part of a systematic toxicological analysis procedure for acidics by gas chromatography-mass spectrometry (GC-MS) after extractive methylation. J Anal Toxicol 1998;in press.
16. Joern WA. Confirmation of low concentrations of urinary benzodiazepines, including alprazolam and triazolam, by GC/MS: An extractive alkylation procedure. J Anal Toxicol 1992;16:363-7.
17. Lisi AM, Kazlauskas R, Trout GJ. Diuretic screening in human urine by gas chromatography-mass spectrometry: use of a macroreticular acrylic copolymer for the efficient removal of the coextracted phase-transfer reagent after derivatization by direct extractive alkvlation. J Chromatogr 1992;581:57-63.
18. Hartvig P, Fagerlund C, Gyllenhaal O. Electron-capture gas chromatography of plasma sulphonylureas after extractive methylation. J Chromatogr 1980;181:17-24.
19. Fagerlund C, Hartvig P, Lindstrom B. Extractive alkylation of sulphonamide diuretics and their determination by electron-capture gas chromatography. J Chromatogr 1979;168:107-16.
20. Hulshoff A, Forch AD. Alkylation with alkylhalides as a derivatization method for the gas chromatographic determination of acidic pharmaceuticals. J Chromatogr 1981;220:275-311.
21. Rivier L, Grunauer C, Saugy M. Direct extractive methylation and automatic GC-MS screening and identification of drugs of abuse and other compounds of potential abuse in sport. In: Mueller RK ed. Proceedings of the 31st international TIAFT meeting, Leipzig. Leipzig: Molinapress, 1993:419-22.
22. Maurer HH. Toxicological analysis of drugs and poisons by GC-MS. Spectroscopy Europe 1994;6:21-3.
23. Pfleger K, Maurer HH, Weber A. Mass spectral library of drugs, poisons, pesticides, pollutants and their metabolites. 3rd ed. Palo Alto, CA: Hewlett Packard, 1998;in press.
24. Kelly JG, OMalley K. Clinical Pharmakokinetics of the Newer ACE Inhibitors. Clin Pharmacokinet 1990;19:177-96.
25. Stimpel M, Bonn R, Koch B, et al. Pharmacology and clinical use of the new ACE-inhibitor moexipnl. Cardiovasc Drug Rev 1995; 13:211-29.
26. McLafferty FW, Turecek F. Interpretation of mass spectra. Mill Valley, CA: University Science Books, 1993.
27. Drummer OH, Kourtis S, lakovidis D. Biotransformation studies of diacid angiotensin converting enzyme inhibitors. Drug Res 1988;38:647-50.
28. Pfleger K, Maurer HH, Weber A. Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Part 4. Weinheim: Wiley-VCH, 1998;in press.
29. Kovats E. Gaschromatographische Charakterisierung organischer Verbindungen. Teil 1. Retentionsindices aliphatischer Halogenide, Alkohole, Aldehyde, und Ketone. Helv Chim Acta 1958;41:1915-32.
30. De Zeeuw RA, Franke JP, Maurer HH, Pfleger K. Gas chromatographic retention indices of toxicologically relevant substances and their metabolites (report of the DFG Commission for Clinical Toxicological Analysis). New York: VCH, 1992.
31. Deutsche Forschungsgemeinschaft, Senatskommission für Klinisch-toxikologische Analytik. J Clin Chem Clin Biochem 1982;20:699.
32. Bathala MS, Weinstein SH, Meeker FS Jr, et al. Quantitative determination of captopril in blood and captopril and its disulfide metabolites in plasma by gas chromatography. J Pharm Sci 1984; 73:340-4.
33. Drummer OH, Jarrott B, Louis WJ. Combined gas chromatographic-mass spectrometric procedure for the measurement of captopril and sulfur-conjugated metabolites of captopril in plasma and urine. J Chromatogr 1984;305:83-93.
34. Jemal M, Ivashkiv E, Ribick M, et al. Determination of SQ 27,519, the active phosphinic acid-carboxylic acid of the prodrug SQ 28,555, in human serum by capillary gas chromatography with nitrogen-phosphorus detection after a two-step denvatization. J Chromatogr 1985;345:299-307.
35. Wong YC, Charles BG. Determination of the angiotensin-converting enzyme inhibitor lisinopril in urine using solid-phase extraction and reversed-phase high-performance liquid chromatography. J Chromatogr B 1995;673:306-10.
36. Arlt JW, Maurer HH. Toxicological detection of ACE inhibitors and their metabolites in urine by GC-MS after extractive alkylation. Proceedings of the 35th international TIAFT meeting, Padova. 1997;155-61.